NCT04697875View on ClinicalTrials.gov

Hemodynamic Effects of Normobaric Hypoxia During Exercise in Patients With Pulmonary Hypertension

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

May 31, 2023

Study Completion Date

May 31, 2023

Conditions
Hypertension, Pulmonary
Interventions
OTHER

Normobaric hypoxia (FiO2 15%)

"Inhalation of deoxygenated air through an altitude simulator (Altitrainer), for approx. 1/2 hour given by a facemask, first at rest and then during exercise."

OTHER

Placebo-ambient air (FiO2 21%)

"Inhalation of room air through an altitude simulator (Altitrainer), for approx. 1/2 hour given by a facemask, first at rest and then during exercise."

Trial Locations (1)

8091

UniversityHospital Zurich, Department of Pulmonology, Zurich

All Listed Sponsors
lead

University of Zurich

OTHER

NCT04697875 - Hemodynamic Effects of Normobaric Hypoxia During Exercise in Patients With Pulmonary Hypertension | Biotech Hunter | Biotech Hunter